Released: September 21, 2021

Medicare should be able to negotiate drug prices

Source: Rep. Susan Wild (D-Pa.), The Hill Opinion

For far too long, the pharmaceutical industry has dictated who in America has access to the medicines they need for their health and well-being.  The industry’s unchecked power to set and keep prescription drug prices high has resulted in one-in-three Americans skipping getting a refill of their prescription, while one-in-four Americans with diabetes have rationed insulin, risking their lives each time. I refuse to accept this as the status quo.

That’s why I recently organized a letter signed by 14 of my colleagues asking our leaders in the House and Senate to allow Medicare to negotiate lower drug prices, and include that language in the budget reconciliation bill currently being negotiated.

Read Full Article: Medicare should be able to negotiate drug prices